期刊文献+

高效液相色谱法测定盐酸纳曲酮多囊泡脂质体的含量 被引量:1

原文传递
导出
摘要 目的:建立高效液相色谱法测定盐酸纳曲酮多囊泡脂质体中盐酸纳曲酮的含量。方法:采用高效液相色谱法测定盐酸纳曲酮的含量,色谱柱为资生堂C_(18)(150mm×4.6mm,5μm)分析柱;流动相:水甲醇-乙腈-三乙胺(85:10:5:0.16,滴加磷酸调pH至4.00)。检测波长:230nm;流速:1.0 mL·min^(-1)柱温:40℃。结果:盐酸纳曲酮在10~100μg·mL^(-1)范围内与峰面积呈良好线性关系(r=0.999 9,n=7),平均回收率为99.63%,RSD为0.85%(n=9)。结论:本方法可准确地进行定性、定量、可用于盐酸纳曲酮多囊泡脂质体的质量控制。
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第19期1659-1660,共2页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献6

  • 1Tucker TK, Ritter AJ. Naltrexone in the treatment of heroin dependence: a literature review [J]. Drug Alcohol Rev,2000, 19(1):73- 82.
  • 2Thomas CP, Wallack SS, Lee S, et al. Swift, researeh to practice: adoption of naltrexone in alcoholism treatment [J].Subst Abuse Treat, 2003,24(1 ) : 1- 11.
  • 3Froehlich J, O'Malley S, Hyyti P, et al. Preclinical and clinical studies on naltrone: what have they taught each othcr[J]. Al- cohol Clin Exp Res,2003,27(3):533 -539.
  • 4Fuller RK, Gordis E. Naltrexone treatment for alcohol de- pendence[J]. N Engl J Med, 2001,345(24):1880 -1771.
  • 5Rohsenow DJ. What place does nahrxone have in the treat- ment of alcoholism CNS[J]. Drug, 2004,18(9) :547 -560.
  • 6王晓梅,唐星,何海冰.多囊脂质体的研究进展[J].中国新药杂志,2006,15(15):1243-1246. 被引量:17

二级参考文献29

  • 1KIM S,TURKER MS,CHI EY,et al.Preparation of multivesicular liposomes[J].Biochim Biophys Acta,1983,728(3):339-348.
  • 2SANJAY KJ,RAJESH KJ,MANISH K,et al.Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium[J].AAPS Pharmscitech,2005,6(1):E35-E41.
  • 3ZHONG HJ,DENG YJ,WANG XM,et al.Multivesicular liposome formulation for the sustained delivery of breviscapine[J].Int J Pharm,2005,301(1-2):15-24.
  • 4DAI CY,WANG BC,ZHAO HW,et al.Preparation and characterization of liposomes-in-alginate (LIA) for protein delivery system[J].Colloids Surf B Biointerfaces,2006,47(2):205-210.
  • 5KIM S.DepoFoam-mediated drug delivery into cerebrospinal fluid[J].Methods Neurosci,1994,21(18):118-131.
  • 6PEPPER CP,HARTOUNIAN M.cGMP manufacturing scale-up of a multivesicular lipid based drug delivery system[J].Pharm Eng,1999,19(2):8-18.
  • 7KATRE NV.Lipid-based multivesicular carriers for sustained delivery of therapeutic proteins and peptides[J].Bio Pharm Int,2001,14(3):8-11.
  • 8KATRE NV,ASHERMAN J,SCHAEFER H,et al.Multivesicular liposome(DepoFoam) technology for the sustained delivery of insulin-like growth factor-Ⅰ(IGF-I)[J].J Pharm Sci,1998,87(11):1341-1346.
  • 9SANKARAM M.A lipid based depot (Depofoam (R) technology) for sustained release drug delivery[J].Prog Lipid Res,2002,41(5):392-406.
  • 10NEW RRC.Influence of liposome characteristics on their properties and fate.[M]// Philippot JR and Schuber F.Liposomes as tools in basic research and industry.Boca Raton:CRC Press,1995:3-20.

共引文献16

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部